CTRI/2018/02/011689已完成1 期
Phase 1 clinical trial for assessment of safety of a multi component botanical formulation SKBBRHM
SK Biolabs1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2000年1月2日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Any toxic side effects after application of SKBBRHM on skin such as irritation, redness, inflammation, itching, fever, nausea, vomiting, shivering, cough, faintness etc.
研究概览
简要总结
Multi component botanical formulation SKBBRHM causes no toxicity in healthy human volunteers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 10.00 Year(s) 至 75.00 Year(s)（—）
- 性别
- All
入选标准
- •Healthy Human volunteers.
排除标准
- •Patients suffering from any disease.
结局指标
主要结局
Any toxic side effects after application of SKBBRHM on skin such as irritation, redness, inflammation, itching, fever, nausea, vomiting, shivering, cough, faintness etc.
时间窗: 30.00 Minutes
次要结局
- Any toxic side effects after application of SKBBRHM on skin such as irritation, redness, inflammation, itching, fever, nausea, vomiting, shivering, cough, faintness etc.(30.0 Days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A trial to test the safety of a herbal formulationCTRI/2018/01/011439SK Biolabs100
已完成
1 期
A trial to test the safety of a drug.CTRI/2017/11/010680SK Biolabs100
已完成
1 期
A trial to test the safety of a drugCTRI/2017/12/010788SK Biolabs100
招募中
2 期
Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral InfectionsAcute Respiratory InfectionNCT05897203Makerere University510
进行中（未招募）
1 期
A phase 1 trial to study how safe and tolerable RP-6306 is, alone or in Combination with RP-3500 or Debio 0123, when administered in patients with certain types of cancerAdvanced solid tumors with CCNE1 amplification or deleteriousmutations in FBXW7 or other proprietary geneMedDRA version: 21.0Level: LLTClassification code: 10049280Term: Solid tumour Class: 10029104CTIS2023-510063-35-00Repare Therapeutics USA Inc.364